Relkin NR, Szabo P, Adamiak B, Burgut T, Monthe C, Lent RW, Younkin S, Younkin L, Schiff R, Weksler ME. 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease. Neurobiol Aging. 2009 Nov;30(11):1728-36. doi: 10.1016/j.neurobiolaging.2007.12.021. Epub 2008 Feb 21., J Neurol Neurosurg Psychiatry. 2015 Sep 29. pii: jnnp-2015-311486. doi: 10.1136/jnnp-2015-311486., 2015 Sep 29
Associated Topics
Related Publications
Reduction of Amyloid in the Brain and Retina After Treatment With IVIG for Mild Cognitive Impairment
American Journal of Alzheimer's Disease & Other Dementias
2020 Feb 12
Five-year outcomes after IVIG for mild cognitive impairment due to alzheimer disease
BMC Neuroscience
2099 Dec 31
Alzheimer abnormalities of the amygdala with Klüver-Bucy syndrome symptoms: an amygdaloid variant of Alzheimer disease
Arch Neurol. 2009 Jan;
2009 Jan 20